Hadlee Simons / Android Authority
Nvidia launched its solely Protect Pill again in 2014, providing a gaming-focused expertise and highly effective internals for the time. The corporate has caught to its Protect TV sequence of Android TV units since then, although.
We wrote an opinion piece final week calling for a rebooted Protect pill, however do you share this sentiment? We posted a ballot contained in the article, and listed below are the outcomes.
Do you wish to see a brand new Protect Pill?
Outcomes
This was a preferred ballot, attracting over 4,300 votes after we posted it on June 18. The most well-liked selection? Properly, 80.59% of respondents stated they do certainly wish to see a brand new Nvidia Protect Pill, making it the winner by a landslide.
We are able to perceive why you’d vote for this feature, as Nvidia’s present Android units take pleasure in a wholesome stage of energy, a ridiculously lengthy dedication to software program updates, and loads of multimedia options. And all of those elements sound like a good suggestion for a pill. The Geforce Now platform (together with different recreation streaming providers) and Android’s tablet-focused overhaul solely make for a extra intriguing prospect.
Associated: Google Stadia versus Geforce Now — Which one is best for you?
In the meantime, 15.71% of polled readers say they’re ready for options and/or pricing. That is clearly necessary, as one thing like a $1,200 Android pill with no redeeming options could be a troublesome promote for Nvidia.
Lastly, solely 3.7% of respondents stated they don’t wish to see a brand new Nvidia Protect Pill. A minimum of one reader steered that an x86-powered pill could be a greater thought, according to conventional Home windows tablets. One other reader reckoned that Android tablets nonetheless have a protracted technique to go.
Feedback
- Yassin Maamoun: I bought my Protect pill approach again in November 2014. It was unimaginable, the gaming expertise was high notch given the restrictions of the time. Could be very curious about a rebooted model. I can see it being very profitable in the event that they up the display screen measurement to 9-10″, bundle in just a few months of Geforce NOW, and add refreshed variations of the stylus and the wi-fi controller that had been accessible with the primary one (which had been each very good). It might be a very simple promote to school college students, they will use it to take notes in school, and recreation on it of their free time.
- Wasn’t the primary defend system the one with a display screen constructed into the controller? I consider it had a cooling fan for the tegra 3 chip inside it? That’s again when android units and tablets had been enjoyable! Proper now I’d in all probability choose that Nvidia launch a Home windows pill sporting an x86 APU. The Google retailer has actually common video games in the intervening time. A minimum of again within the Tegra days, the defend units had their very own suite of customised video games to run on their specialised {hardware}.
- I don’t suppose so. It’s not a superb time for any pill not made by Apple. Pill expertise on Android leaves lots to be desired.
- Daniel: Steam Deck. AMD slapped Nvidia proper throughout the face with this handheld. There’s area within the moveable market, however “simply one other” gaming pill received’t stand an opportunity in opposition to the steam deck. Nvidia should give you one thing revolutionary, however I don’t see that taking place when it put zero effort in protecting the defend pill related.
- The Bunny: Wouldn’t it make extra sense as a handheld? Just like the nintendo swap, which has just about the identical SoC as a Protect, with all the things else it’s essential to recreation? Or a Steam Deck? Or one of many different various android handhelds or units to carry your telephone, including controllers? The enchantment right here could be lengthy help to the system. Downside being, on the probably worth level…there are a ton of choices on the market and a brand new android providing won’t catch on.